| Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma C Jerónimo, H Usadel, R Henrique, J Oliveira, C Lopes, WG Nelson, ... Journal of the National Cancer Institute 93 (22), 1747-1752, 2001 | 392 | 2001 |
| A quantitative promoter methylation profile of prostate cancer C Jerónimo, R Henrique, MO Hoque, E Mambo, FR Ribeiro, G Varzim, ... Clinical Cancer Research 10 (24), 8472-8478, 2004 | 325 | 2004 |
| TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas, paired HGPIN lesions N Cerveira, FR Ribeiro, A Peixoto, V Costa, R Henrique, C Jerönimo, ... Neoplasia 8 (10), 826-832, 2006 | 306 | 2006 |
| Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects MO Hoque, O Topaloglu, S Begum, R Henrique, E Rosenbaum, ... Journal of Clinical Oncology 23 (27), 6569-6575, 2005 | 300 | 2005 |
| Mitochondrial mutations in early stage prostate cancer and bodily fluids C Jeronimo, S Nomoto, OL Caballero, H Usadel, R Henrique, G Varzim, ... Oncogene 20 (37), 5195-5198, 2001 | 295 | 2001 |
| Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer C Jernimo, H Usadel, R Henrique, C Silva, J Oliveira, C Lopes, ... Urology 60 (6), 1131-1135, 2002 | 258 | 2002 |
| Epigenetics in prostate cancer: biologic and clinical relevance C Jerónimo, PJ Bastian, A Bjartell, GM Carbone, JWF Catto, SJ Clark, ... European urology 60 (4), 753-766, 2011 | 257 | 2011 |
| BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment S Begum, E Rosenbaum, R Henrique, Y Cohen, D Sidransky, WH Westra Modern Pathology 17 (11), 1359-1363, 2004 | 233 | 2004 |
| Diagnostic and prognostic epigenetic biomarkers in cancer P Costa-Pinheiro, D Montezuma, R Henrique, C Jerónimo Epigenomics 7 (6), 1003-1015, 2015 | 226 | 2015 |
| Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer N Pértega-Gomes, JR Vizcaíno, V Miranda-Gonçalves, C Pinheiro, J Silva, ... BMC cancer 11, 1-9, 2011 | 221 | 2011 |
| Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma AL Carvalho, C Jeronimo, MM Kim, R Henrique, Z Zhang, MO Hoque, ... Clinical Cancer Research 14 (1), 97-107, 2008 | 213 | 2008 |
| A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions P Pimentel-Nunes, M Dinis-Ribeiro, JB Soares, R Marcos-Pinto, C Santos, ... Endoscopy 44 (03), 236-246, 2012 | 212 | 2012 |
| Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro MJ Valente, AF Baltazar, R Henrique, L Estevinho, M Carvalho Food and Chemical Toxicology 49 (1), 86-92, 2011 | 212 | 2011 |
| Genome-wide promoter analysis uncovers portions of the cancer methylome MO Hoque, MS Kim, KL Ostrow, J Liu, GBA Wisman, HL Park, ML Poeta, ... Cancer research 68 (8), 2661-2670, 2008 | 206 | 2008 |
| Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples VL Costa, R Henrique, SA Danielsen, S Duarte-Pereira, M Eknaes, ... Clinical Cancer Research 16 (23), 5842-5851, 2010 | 203 | 2010 |
| Molecular detection of prostate cancer: a role for GSTP1 hypermethylation R Henrique, C Jerónimo European urology 46 (5), 660-669, 2004 | 180 | 2004 |
| DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types V Constâncio, SP Nunes, R Henrique, C Jerónimo Cells 9 (3), 624, 2020 | 154 | 2020 |
| Profiling DNA methylation based on next-generation sequencing approaches: new insights and clinical applications D Barros-Silva, CJ Marques, R Henrique, C Jerónimo Genes 9 (9), 429, 2018 | 150 | 2018 |
| High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients R Henrique, FR Ribeiro, D Fonseca, MO Hoque, AL Carvalho, VL Costa, ... Clinical cancer research 13 (20), 6122-6129, 2007 | 146 | 2007 |
| Quantitative RARβ2 hypermethylation: a promising prostate cancer marker C Jerónimo, R Henrique, MO Hoque, FR Ribeiro, J Oliveira, D Fonseca, ... Clinical Cancer Research 10 (12), 4010-4014, 2004 | 144 | 2004 |
Carmen JeronimoPortuguese Oncology Institute of Porto在 ipoporto.min-saude.pt 的电子邮件经过验证
